Published • loading... • Updated
Scientists uncover how inflammatory molecules drive cancer progression
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Scientists uncover how inflammatory molecules drive cancer progression
Colorectal cancer may resist immunotherapy not only because tumor cells acquire genetic changes, but also because inflammatory signals can reprogram their epigenetic state, according to a new study from researchers at Juntendo University in Japan. The work identifies interleukin-26, or IL-26, as a central driver of this process. The cytokine appears to enter colorectal cancer […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
